[Thread] What is the significance of the license agreement #JnJ will grant @aspenpharma to fill and finish an Aspen brand of #JnJ's #COVID jab?
Aspen will be able to sell their jabs to African countries. Currently they can't, they have to hand the jabs back to JnJ to sell.
Aspen will be able to sell their jabs to African countries. Currently they can't, they have to hand the jabs back to JnJ to sell.
2. #JnJ is essentially giving Aspen a voluntary license to make (fill and finish) its vaccine and sharing the intellectual property rights with Aspen to do this.
3. Africa imports 99% of its vaccines from outside the continent. Having an African manufacturer (to fill and finish) that will only supply #COVID19 jabs to Africa will increase access to supplies on the continent.
4. Previously, JnJ sold some of the jabs filled and finished by Aspen in SA, to European countries while SA and other African countries were in desperate need of them. So jabs made on a continent with little supply went to countries with lots of supply. That will now change.
5. Aspen hopes that its license agreement with #JnJ will serve as a blueprint on how to enable local production of vaccines in Africa. It plans to produce 400 million doses of #JnJ's jab per year under the brand name Aspenovax.
6. Stephen Saad, Aspen: More booster #COVID19 vaccine doses have been administered globally than first doses in Africa.
7. #JnJ has also done tech transfer (sharing their know-how) with Aspen when they started to fill and finish JnJ's jabs under their current agreement. What is tech transfer and what happens when drug companies refuse to do it? More here. bit.ly/3D7dRv8
• • •
Missing some Tweet in this thread? You can try to
force a refresh
